Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
2,035.00Prev. Close
2,025.40Volume
6,03,128Total traded value
122 CrUpper Circuit
2,233.80Lower Circuit
1,827.80Fundamentals
| Market Cap | ₹92,501Cr |
| ROE | 22.03% |
| P/E Ratio(TTM) | 21.28 |
| EPS(TTM) | 95.18 |
| P/B Ratio | 4.71 |
| Dividend Yield | 0.59% |
| Industry P/E | 33.27 |
| Book Value | 429.82 |
| Debt to Equity | 0.32 |
| Face Value | 2 |
Understand Fundamentals
Financials
About Lupin
Lupin is a global pharmaceutical leader committed to improving lives by providing a portfolio spanning generics, complex generics, specialty medicines, and biosimilars worldwide. The company's core purpose is to catalyze treatments that transform hope into healing, which guides every decision and action the company undertakes. Demonstrating its market strength, Lupin holds the third position in the United States in terms of total prescriptions dispensed.;
| Parent Organisation | Lupin Limited |
| Managing Director | NA |
| NSE Symbol | LUPIN |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Top Mutual Funds Invested(4)
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | NA (0.00%) | 40.83 | ||
| Cipla | NA (0.00%) | 22.69 | ||
| Dr Reddy's Laboratories | NA (0.00%) | 18.19 | ||
| Zydus Lifesciences | NA (0.00%) | 18.62 |